These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33985827)

  • 21. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the skin-liver capsule distance on the accuracy of ultrasound diagnosis for liver steatosis and fibrosis.
    Uchikawa S; Kawaoka T; Fujino H; Ono A; Nakahara T; Murakami E; Yamauchi M; Miki D; Imamura M; Aikata H
    J Med Ultrason (2001); 2022 Jul; 49(3):443-450. PubMed ID: 35524897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Jang JK; Lee ES; Seo JW; Kim YR; Kim SY; Cho YY; Lee DH
    Radiology; 2022 Oct; 305(1):118-126. PubMed ID: 35727151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB
    Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Diagnosis of Nonalcoholic Fatty Liver Disease with Ultrasound Attenuation Imaging in a Biopsy-Proven Cohort.
    Huang YL; Bian H; Zhu YL; Yan HM; Wang WP; Xia MF; Dong Y; Gao X
    Acad Radiol; 2023 Sep; 30 Suppl 1():S155-S163. PubMed ID: 37407373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-Based Quantification of Fibrosis and Steatosis with a New Software Considering Transient Elastography as Reference in Patients with Chronic Liver Diseases.
    Popa A; Șirli R; Popescu A; Bâldea V; Lupușoru R; Bende F; Cotrău R; Sporea I
    Ultrasound Med Biol; 2021 Jul; 47(7):1692-1703. PubMed ID: 33832824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
    Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography.
    Bauer DJ; Matic V; Mare R; Maiocchi L; Chromy D; Müllner-Bucsics T; Mandorfer M; Mustapic S; Sporea I; Ferraioli G; Grgurevic I; Reiberger T
    Ultraschall Med; 2023 Apr; 44(2):169-178. PubMed ID: 35226932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.
    Mendoza YP; Rodrigues SG; Delgado MG; Murgia G; Lange NF; Schropp J; Montani M; Dufour JF; Berzigotti A
    Liver Int; 2022 Jan; 42(1):102-111. PubMed ID: 34821035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
    Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
    J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis.
    Ayonrinde OT; Zelesco M; Welman CJ; Abbott S; Adris N
    Intern Med J; 2022 Apr; 52(4):640-650. PubMed ID: 34726820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD.
    Cassinotto C; Boursier J; Paisant A; Guiu B; Irles-Depe M; Canivet C; Aube C; de Ledinghen V
    Hepatology; 2021 Jun; 73(6):2196-2205. PubMed ID: 33236409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
    Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
    J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When the liver gets stiff, the tough get moving.
    Nguyen TH; Wardell R; Chitturi S; Teoh N; Farrell G
    J Gastroenterol Hepatol; 2020 Jun; 35(6):953-959. PubMed ID: 31867782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease.
    P V Alves V; T Trout A; Dewit M; Mouzaki M; Arce-Clachar AC; S Bramlage K; R Dillman J; A Xanthakos S
    Child Obes; 2023 Oct; 19(7):461-469. PubMed ID: 36269577
    [No Abstract]   [Full Text] [Related]  

  • 38. The performance of shear wave elastography on evaluating liver changes in obese and overweight children.
    Sağlam NÖ; Aksoy S; Kazancı SY; Palabıyık F; Hatipoğlu SS; İnci E
    Turk J Pediatr; 2021; 63(4):575-583. PubMed ID: 34449139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
    Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
    World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of strain elastography and shear wave elastography in diagnosis of fibrosis in nonalcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Matsuda T
    J Med Ultrason (2001); 2023 Apr; 50(2):187-195. PubMed ID: 36801991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.